Edition:
United Kingdom

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

186.18USD
4:51pm BST
Change (% chg)

$-1.72 (-0.91%)
Prev Close
$187.89
Open
$187.34
Day's High
$187.34
Day's Low
$185.91
Volume
69,318
Avg. Vol
495,998
52-wk High
$227.12
52-wk Low
$163.02

Select another date:

Tue, Aug 14 2018

Photo

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

UPDATE 1-Icahn reverses position on Cigna-Express Scripts deal

Aug 13 Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Cigna-Express Scripts deal gets backing from another proxy firm

Aug 13 Cigna Corp said Glass Lewis & Co on Monday recommended its shareholders vote in favour for the proposed $52 billion acquisition of pharmacy benefits manager Express Scripts, the second proxy advisory firm to support the deal.

Advisory firm ISS backs Cigna's Express Scripts buy

Shareholder advisory firm Institutional Shareholder Services Inc (ISS) on Friday recommended that Cigna Corp investors vote for the health insurer's $52 billion purchase of pharmacy benefits manager Express Scripts , a deal that has been opposed by activist investor Carl Icahn.

Advisory firm ISS backs Cigna's Express Scripts buy

Aug 10 Shareholder advisory firm Institutional Shareholder Services Inc (ISS) on Friday recommended that Cigna Corp investors vote for the health insurer's $52 billion purchase of pharmacy benefits manager Express Scripts, a deal that has been opposed by activist investor Carl Icahn.

Glenview backs Cigna-Express Scripts deal after Icahn criticism

Hedge fund Glenview Capital Management on Thursday backed health insurer Cigna Corp's deal to buy pharmacy benefit manager Express Scripts in the face of stiff opposition from activist investor Carl Icahn ahead of a shareholder vote.

UPDATE 2-Glenview backs Cigna-Express Scripts deal after Icahn criticism

Aug 9 Hedge fund Glenview Capital Management on Thursday backed health insurer Cigna Corp's deal to buy pharmacy benefit manager Express Scripts in the face of stiff opposition from activist investor Carl Icahn ahead of a shareholder vote.

Icahn ratchets up pressure against Cigna-Express Scripts deal

Aug 9 Activist investor Carl Icahn fired the latest salvo against Cigna Corp's deal to buy pharmacy benefit manager Express Scripts, saying drug rebates that PBMs receive from drugmakers will ultimately be eliminated, dealing a blow to the industry.

Icahn urges Cigna shareholders to vote against Express Scripts deal

Activist investor Carl Icahn on Tuesday urged Cigna Corp shareholders to vote against the health insurer's $52 billion purchase of Express Scripts Holding Co , citing regulatory hurdles and the growing threat from Amazon. | Video

Select another date: